resiquimod has been researched along with dextrothyroxine in 2 studies
| Studies (resiquimod) | Trials (resiquimod) | Recent Studies (post-2010) (resiquimod) | Studies (dextrothyroxine) | Trials (dextrothyroxine) | Recent Studies (post-2010) (dextrothyroxine) |
|---|---|---|---|---|---|
| 465 | 14 | 318 | 7,511 | 855 | 3,349 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Huang, Y; Kuo, JC; Lee, RJ; Zhang, C; Zhang, Z | 1 |
2 other study(ies) available for resiquimod and dextrothyroxine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Emulsions; HMGB1 Protein; Imidazoles; Ivermectin; Squalene; Toll-Like Receptor 7 | 2022 |